A new state program is designed to make sure doctors are up-to-date and following recommendations when they prescribe medicine for the mentally ill. The two-year Michigan Pharmacy Quality Improvement Project is aimed at providing proper medication for the 450,000 to 650,000 state residents who suffer mental illness or emotional disorders. Advocates for the mentally ill complain that Michigan's mental health system does not offer a program for recovery, including a regimen of the latest drugs and proper supervision.
Drug manufacturer Eli Lilly and Co. is financing the new program. It will allow the state to analyze prescriptions for Medicaid recipients to identify patterns inconsistent with industry guidelines. The review likely will identify a small group of doctors who regularly violate guidelines, Janet Olszewski, director of the state Department of Community Health. Those doctors will receive educational material.
Another company assisting the state with the program, Comprehensive NeuroScience Inc. of White Plains, N.Y., will monitor doctors' performance.